Edesa Biotech, Inc.
100 Spy Court
Markham, Ontario, Canada L3R 5H6
March
4, 2020
United States Securities and Exchange Commission
Attention: Ada D. Sarmento
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
RE: Edesa Biotech, Inc. (the “Company”)
Registration Statement on Form S-1 (the “Registration
Statement”)
File
Number 333-236608
Dear Ms. Sarmento:
The
Company hereby requests, pursuant to Rule 461 promulgated under the
Securities Act of 1933, as amended, acceleration of the
effectiveness of the Registration Statement so that such
Registration Statement will become effective as of 5:00 P.M. on
Friday, March 6, 2020, or as soon thereafter as
practicable.
|
|
Very truly yours,
|
|
|
|
|
|
|
|
|
EDESA BIOTECH, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Kathi Niffenegger
|
|
|
|
Name: Kathi Niffenegger
|
|
|
|
Title: Chief Financial Officer
|
|